In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019
- Resource Type
- Short Communication
- Source
- In
Diagnostic Microbiology & Infectious Disease September 2021 101(1) - Subject
- Language
- ISSN
- 0732-8893